A citation-based method for searching scientific literature

Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
Times Cited: 80



Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella, Arthur P Grollman, Tong-Chuan He, Yiping He, Ralph H Hruban, George I Jallo, Nils Mandahl, Alan K Meeker, Fredrik Mertens, George J Netto, B Ahmed Rasheed, Gregory J Riggins, Thomas A Rosenquist, Mark Schiffman, Ie-Ming Shih, Dan Theodorescu, Michael S Torbenson, Victor E Velculescu, Tian-Li Wang, Nicolas Wentzensen, Laura D Wood, Ming Zhang, Roger E McLendon, Darell D Bigner, Kenneth W Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan. Proc Natl Acad Sci U S A 2013
Times Cited: 860




List of shared articles



Times cited

Telomeres and telomerase in oncogenesis.
Tomasz Trybek, Artur Kowalik, Stanisław Góźdź, Aldona Kowalska. Oncol Lett 2020
12

TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.
Jie Tan, Rengyun Liu, Guangwu Zhu, Christopher B Umbricht, Mingzhao Xing. Proc Natl Acad Sci U S A 2020
9

TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.
Yao Yu, Dan Fan, Xinmao Song, Kaveh Zakeri, Linda Chen, Jung Kang, Sean McBride, C Jillian Tsai, Lara Dunn, Eric Sherman,[...]. JCO Precis Oncol 2021
0

The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
Joanna J Phillips, Henry Gong, Katharine Chen, Nancy M Joseph, Jessica van Ziffle, Boris C Bastian, James P Grenert, Cassie N Kline, Sabine Mueller, Anuradha Banerjee,[...]. Brain Pathol 2019
42

Occurrence, functionality and abundance of the TERT promoter mutations.
Sivaramakrishna Rachakonda, Jörg D Hoheisel, Rajiv Kumar. Int J Cancer 2021
1

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing. Proc Natl Acad Sci U S A 2021
1

Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Josh Lewis Stern, Grace Hibshman, Kevin Hu, Sarah E Ferrara, James C Costello, William Kim, Pablo Tamayo, Thomas R Cech, Franklin W Huang. Mol Cancer Res 2020
8

TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Juan J Andrés-Lencina, Sivaramakrishna Rachakonda, Zaida García-Casado, Nalini Srinivas, Alexander Skorokhod, Celia Requena, Virtudes Soriano, Rajiv Kumar, Eduardo Nagore. Int J Cancer 2019
23


TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
16

Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma.
Francesca Pezzuto, Francesco Izzo, Pasquale De Luca, Elio Biffali, Luigi Buonaguro, Fabiana Tatangelo, Franco Maria Buonaguro, Maria Lina Tornesello. Cancers (Basel) 2021
0

Targeting telomerase for cancer therapy.
Adam N Guterres, Jessie Villanueva. Oncogene 2020
15

Revisiting Telomere Shortening in Cancer.
Keiji Okamoto, Hiroyuki Seimiya. Cells 2019
43